Thromboxane b2

Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.

Cross Reference

Introduction

To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Thromboxane b2?

Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Thromboxane b2

MeSH term MeSH ID Detail
Acute Kidney Injury D058186 34 associated lipids
Airway Remodeling D056151 3 associated lipids
Acute Coronary Syndrome D054058 11 associated lipids
Hypoalphalipoproteinemias D052456 5 associated lipids
Atherosclerosis D050197 85 associated lipids
Dyslipidemias D050171 7 associated lipids
Cholecystitis, Acute D041881 1 associated lipids
Pulmonary Disease, Chronic Obstructive D029424 16 associated lipids
Metabolic Syndrome D024821 44 associated lipids
Coronary Stenosis D023921 6 associated lipids
Per page 10 20 50 100 | Total 293

PubChem Associated disorders and diseases

What pathways are associated with Thromboxane b2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Thromboxane b2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Thromboxane b2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

What genes are associated with Thromboxane b2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Thromboxane b2

Download all related citations
Per page 10 20 50 100 | Total 6367
Authors Title Published Journal PubMed Link
Ersöz G et al. Effect of submaximal and incremental upper extremity exercise on platelet function and the role of blood shear stress. 2002 Thromb. Res. pmid:12676189
Ersöz G et al. The effect of submaximal exercise on platelet aggregation during late follicular and midluteal phases in women. 2002 Thromb. Res. pmid:12590951
Schelzig H et al. Role of recombinant hirudin in a pig-to-human lung transplantation model. 2002 Transplant. Proc. pmid:12270449
Huang CG et al. Effect of berberine on arachidonic acid metabolism in rabbit platelets and endothelial cells. 2002 Thromb. Res. pmid:12297129
Lees P and Landoni MF Pharmacodynamics and enantioselective pharmacokinetics of racemic carprofen in the horse. 2002 J. Vet. Pharmacol. Ther. pmid:12485349
Lassus P et al. Pulmonary prostacyclin is associated with less severe respiratory distress in preterm infants. 2002 Early Hum. Dev. pmid:11893431
Venuto R et al. Enhanced vascular effects of the Ca(2+) channel agonist Bay K 8644 in pregnant rabbits. 2002 Am. J. Physiol. Regul. Integr. Comp. Physiol. pmid:11893597
Tang L et al. [Relationship between cyclooxygenase-2 protein expression, prostaglandins levels and biologic behavior in ovarian carcinoma tissue]. 2002 Zhonghua Fu Chan Ke Za Zhi pmid:12487927
Wainwright CL et al. NCX4016 (NO-aspirin) reduces infarct size and suppresses arrhythmias following myocardial ischaemia/reperfusion in pigs. 2002 Br. J. Pharmacol. pmid:11959790
Tuersun K and Huang Y [Changes of blood vessel active substances in acute pulmonary embolism induced by echinococus granulous cyst in rabbits]. 2002 Zhonghua Jie He He Hu Xi Za Zhi pmid:12490126
Sheu JR et al. Mechanisms involved in the antiplatelet activity of midazolam in human platelets. 2002 Anesthesiology pmid:11873041
Horiguchi T et al. Study on the usefulness of seratrodast in the treatment of chronic pulmonary emphysema. 2002 Arzneimittelforschung pmid:12442639
Zaitsu M et al. Induction of thromboxane A2 synthesizing enzymes in DMSO-induced granulocytic differentiation of HL-60 cells. 2002 Prostaglandins Leukot. Essent. Fatty Acids pmid:12468261
Thomson M et al. The use of ginger (Zingiber officinale Rosc.) as a potential anti-inflammatory and antithrombotic agent. 2002 Prostaglandins Leukot. Essent. Fatty Acids pmid:12468270
Minuz P et al. Increased oxidative stress and platelet activation in patients with hypertension and renovascular disease. 2002 Circulation pmid:12451006
Leahy KM et al. Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo. 2002 Cancer Res. pmid:11830509
Ma LP et al. Inhibition of platelet aggregation and expression of alpha granule membrane protein 140 and thromboxane B2 with pravastatin therapy for hypercholesterolemia. 2002 J Assoc Acad Minor Phys pmid:11852667
Ochi T and Goto T Differential effect of FR122047, a selective cyclo-oxygenase-1 inhibitor, in rat chronic models of arthritis. 2002 Br. J. Pharmacol. pmid:11834626
De La Cruz JP et al. Effects of the selective inhibition of platelet thromboxane synthesis on the platelet-subendothelium interaction. 2002 Br. J. Pharmacol. pmid:12429581
Bruno A et al. Aspirin and urinary 11-dehydrothromboxane B(2) in African American stroke patients. 2002 Stroke pmid:11779889
Kudolo GB et al. Effect of the ingestion of Ginkgo biloba extract on platelet aggregation and urinary prostanoid excretion in healthy and Type 2 diabetic subjects. 2002 Thromb. Res. pmid:12590952
Obase Y et al. Effects of pranlukast on chemical mediators in induced sputum on provocation tests in atopic and aspirin-intolerant asthmatic patients. 2002 Chest pmid:11796443
Gordon SM et al. Peripheral prostanoid levels and nonsteroidal anti-inflammatory drug analgesia: replicate clinical trials in a tissue injury model. 2002 Clin. Pharmacol. Ther. pmid:12189364
Van Hecken A et al. Effects of enteric-coated, low-dose aspirin on parameters of platelet function. 2002 Aliment. Pharmacol. Ther. pmid:12197849
Gómez-Gaviro MV et al. Structure-function relationship and role of tumor necrosis factor-alpha-converting enzyme in the down-regulation of L-selectin by non-steroidal anti-inflammatory drugs. 2002 J. Biol. Chem. pmid:12147693
Khan AA et al. In vivo selectivity of a selective cyclooxygenase 2 inhibitor in the oral surgery model. 2002 Clin. Pharmacol. Ther. pmid:12152003
Tzanakakis GN et al. The preventive effect of ketoconazole on experimental metastasis from a human pancreatic carcinoma may be related to its effect on prostaglandin synthesis. 2002 Int J Gastrointest Cancer pmid:12630766
Kirchheiner J et al. Enantiospecific effects of cytochrome P450 2C9 amino acid variants on ibuprofen pharmacokinetics and on the inhibition of cyclooxygenases 1 and 2. 2002 Clin. Pharmacol. Ther. pmid:12152005
Wang L et al. Enhancement of human platelet activation by the combination of low concentrations of collagen and rabbit anticardiolipin antibodies. 2002 Br. J. Haematol. pmid:12199800
Park CH et al. Investigations of new lead structures for the design of novel cyclooxygenase-2 inhibitors. 2002 Eur J Med Chem pmid:12204472
Cipollone F et al. Association between enhanced soluble CD40L and prothrombotic state in hypercholesterolemia: effects of statin therapy. 2002 Circulation pmid:12135935
Association between ibuprofen, aspirin therapy found. 2002 J Am Dent Assoc pmid:12136787
Rinder HM et al. Effects of meloxicam on platelet function in healthy adults: a randomized, double-blind, placebo-controlled trial. 2002 J Clin Pharmacol pmid:12162470
Wong DA et al. Discrete role for cytosolic phospholipase A(2)alpha in platelets: studies using single and double mutant mice of cytosolic and group IIA secretory phospholipase A(2). 2002 J. Exp. Med. pmid:12163563
Knijff-Dutmer EA et al. Platelet function is inhibited by non-selective non-steroidal anti-inflammatory drugs but not by cyclo-oxygenase-2-selective inhibitors in patients with rheumatoid arthritis. 2002 Rheumatology (Oxford) pmid:11961179
Hayashi M et al. The levels of five markers of hemostasis and endothelial status at different stages of normotensive pregnancy. 2002 Acta Obstet Gynecol Scand pmid:11966476
Leese PT et al. Valdecoxib does not impair platelet function. 2002 Am J Emerg Med pmid:12098171
Tsukamoto H et al. Simultaneous quantification of prostaglandins, isoprostane and thromboxane in cell-cultured medium using gas chromatography-mass spectrometry. 2002 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. pmid:12076690
Sakai H et al. E3040 sulphate, a novel thromboxane synthase inhibitor, blocks the Cl- secretion induced by platelet-activating factor in isolated rat colon. 2002 Br. J. Pharmacol. pmid:12023941
Jung K et al. The effect of dietary intervention through the modification of fatty acids composition and antioxidant vitamin intake on plasma TXB(2) level in Korean postmenopausal women with hypercholesterolemia. 2002 J. Korean Med. Sci. pmid:12068132
Jung YS et al. Antithrombotic effect of onion in streptozotocin-induced diabetic rat. 2002 Prostaglandins Leukot. Essent. Fatty Acids pmid:12054917
van Kraaij DJ et al. A comparison of the effects of nabumetone vs meloxicam on serum thromboxane B2 and platelet function in healthy volunteers. 2002 Br J Clin Pharmacol pmid:12047490
Appleyard CB et al. Temporal changes in colonic vascular architecture and inflammatory mediator levels in animal models of colitis. 2002 Dig. Dis. Sci. pmid:12353846
Saldeen P et al. Structural, functional and circulatory placental changes associated with impaired glucose metabolism. 2002 Eur. J. Obstet. Gynecol. Reprod. Biol. pmid:12381475
Zhang H et al. [Perioperative lung injury in ventricular septal defect with severe pulmonary hypertension, a clinical study of 31 cases]. 2002 Zhonghua Yi Xue Za Zhi pmid:12425808
Jones CJ et al. In vivo effects of meloxicam and aspirin on blood, gastric mucosal, and synovial fluid prostanoid synthesis in dogs. 2002 Am. J. Vet. Res. pmid:12428662
Buluç M et al. Effect of misoprostol and indomethacin on cyclooxygenase induction and eicosanoid production in carrageenan-induced air pouch inflammation in rats. 2002 Prostaglandins Other Lipid Mediat. pmid:12428691
Gray PA et al. Effects of non-steroidal anti-inflammatory drugs on cyclo-oxygenase and lipoxygenase activity in whole blood from aspirin-sensitive asthmatics vs healthy donors. 2002 Br. J. Pharmacol. pmid:12429575
Valeri CR et al. Circulation and hemostatic function of autologous fresh, liquid-preserved, and cryopreserved baboon platelets transfused to correct an aspirin-induced thrombocytopathy. 2002 Transfusion pmid:12430680
Ferlito M et al. Implication of Galpha i proteins and Src tyrosine kinases in endotoxin-induced signal transduction events and mediator production. 2002 J. Endotoxin Res. pmid:12701623